ELI LILLY CEO DAVID RICKS: NOT DISAPPOINTED BY RESULTS OF ORAL WEIGHT LOSS DRUG - CNBC INTERVIEW
ELI LILLY CEO DAVID RICKS: HAVEN'T SEEN SAFETY CONCERNS FOR ORAL WEIGHT LOSS DRUG DURING CLINICAL TRIALS - CNBC
Source text:
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.